Page 2 - Ascites News Today

Background: Paracentesis is commonly undertaken in patients with cancer-related ascites. Aim: To systematically investigate the symptomatic benefits and harms experienced by patients with cancer undergoing paracentesis using real-world data in the palliative care setting. Design: Prospective, multisite, observational, consecutive cohort study. Benefits and harms of paracentesis were assessed between 01/07/2018 and 31/02/2021 as part of routine clinical assessments by treating clinicians at four ...

These new thresholds are based on high-quality prospective data drawn from four randomized controlled trials.

Adding the IV drug to loop diuretics in the ADVOR trial improved decongestion success in volume-overloaded patients with acute decompensated heart failure, researchers reported.

A reduction in hepatic PPG soon after implantation of a transjugular intrahepatic portosystemic shunt was associated with improved ascites control at 6 weeks in a study published in Hepatology.

Alcohol-associated liver disease kills more people in US states with fewer gastroenterologists per capita.

About half of all liver mortality is attributable to alcoholic-associated liver disease, and transplantation is the sole alternative when corticosteroids dont work.

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature live-cell encapsulation technology

According to a new study, Ayurvedic formulations can now treat ascites, a condition in which fluid collects in spaces within the abdomen.

Patients suffering from ascites -- a condition in which fluid collects in spaces within the abdomen -- can be treated by Ayurvedic poly-herbal drug that has potential not only to slow down the progression of chronic kidney disease but also restore normalcy in functional parameters of the vital organ, a team of researchers has claimed. ���� Ayurvedic Poly-Herbal Drug Can Help Kidney Recovery: Study.

A large case series of metastatic breast cancer patients with pseudocirrhosis found that almost all such patients had hormone receptor–positive disease as well as extensive liver metastases.